GLOBUS MED INC's ticker is GMED and the CUSIP is 379577208. A total of 306 filers reported holding GLOBUS MED INC in Q4 2019. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $188,000 | -10.9% | 3,198 | -22.5% | 0.00% | -50.0% |
Q3 2019 | $211,000 | +70.2% | 4,127 | +39.8% | 0.00% | +100.0% |
Q2 2019 | $124,000 | -31.5% | 2,952 | -19.0% | 0.00% | 0.0% |
Q1 2019 | $181,000 | -3.2% | 3,643 | -15.5% | 0.00% | -50.0% |
Q4 2018 | $187,000 | +23.8% | 4,313 | +62.3% | 0.00% | 0.0% |
Q3 2018 | $151,000 | +16.2% | 2,657 | +2.9% | 0.00% | 0.0% |
Q2 2018 | $130,000 | -23.1% | 2,581 | -24.0% | 0.00% | 0.0% |
Q1 2018 | $169,000 | +10.5% | 3,394 | -9.0% | 0.00% | 0.0% |
Q4 2017 | $153,000 | +45.7% | 3,730 | +5.7% | 0.00% | 0.0% |
Q3 2017 | $105,000 | -7.9% | 3,529 | +2.8% | 0.00% | 0.0% |
Q2 2017 | $114,000 | +14.0% | 3,434 | +2.0% | 0.00% | 0.0% |
Q1 2017 | $100,000 | +25.0% | 3,366 | +4.8% | 0.00% | 0.0% |
Q4 2016 | $80,000 | +100.0% | 3,213 | +81.7% | 0.00% | +100.0% |
Q3 2016 | $40,000 | -64.3% | 1,768 | -63.1% | 0.00% | -66.7% |
Q2 2016 | $112,000 | – | 4,792 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 589,100 | $45,137,000 | 24.71% |
Sterling Investment Advisors, Ltd. | 188,123 | $14,414,000 | 4.29% |
Godshalk Welsh Capital Management, Inc. | 73,748 | $5,651,000 | 3.52% |
Pembroke Management, LTD | 601,447 | $46,083,000 | 3.47% |
Integral Health Asset Management, LLC | 150,000 | $11,493,000 | 3.30% |
XXEC, Inc. | 51,925 | $3,978,000 | 3.03% |
PARADIGM CAPITAL MANAGEMENT INC/NY | 615,000 | $47,122,000 | 2.42% |
Van Berkom & Associates Inc. | 946,997 | $72,559,000 | 2.20% |
RTW INVESTMENTS, LP | 1,670,811 | $128,018,000 | 1.93% |
Sivik Global Healthcare LLC | 95,000 | $7,279,000 | 1.74% |